James DArecca - Aug 10, 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Signature
/s/ James C. D'Arecca
Stock symbol
TXMD
Transactions as of
Aug 10, 2021
Transactions value $
-$81,203
Form type
4
Date filed
8/12/2021, 09:33 PM
Previous filing
Jul 2, 2021
Next filing
Apr 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Options Exercise +217K 217K Aug 10, 2021 Direct F1
transaction TXMD Common Stock Sale -$81.2K -93.3K -42.98% $0.87* 124K Aug 12, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Options Exercise $0 -217K -33.33% $0.00 434K Aug 10, 2021 Common Stock 217K $0.00 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 10, 2021, the reporting person received 217,167 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021.
F2 The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
F3 This transaction was executed in multiple trades at prices ranging from $0.87 to $0.88. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F4 Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
F5 The RSUs vest in three equal installments annually beginning June 1, 2021 (the one-year anniversary of the date of the reporting person's appointment as Chief Financial Officer), becoming fully vested on June 1, 2023.